logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

KEYNOTE-028: pembrolizumab shows efficacy in ovarian cancer

Active in advanced recurrent disease, with safety profile consistent vs other studies.